Skip to main content
. 2018 Jun 14;7:e35518. doi: 10.7554/eLife.35518

Figure 3. Presynaptic Tnc and integrin are critical for neurotransmitter release.

(A–L) Representative traces and summary bar graph for mEJPs and EJPs recorded at 0.8 mM Ca2+ from muscle 6 of indicated genotypes. The number of samples examined is indicated in each bar. (A–C) Neuronal knockdown of tnc significantly reduces the mEJPs frequency. (D–F) Neuronal but not muscle expression of Tnc can rescue the mEJPs frequency and EJP amplitude at tnc mutant NMJs. (G–L) The mean mEJPs frequency is dramatically reduced when mys/βPS integrin or if/αPS2 are knocked down in the neurons. Knockdown of if/αPS2 also induces slight reduction of the mean mEJPs amplitude and occasionally muscle attachment defects. (M–O) The trans-heterozygotes (mys/+;; tnc/+) show enhancement of phenotypes compared with individual heterozygotes, indicating that tnc and mys interact genetically. Bars indicate mean ±SEM. ns, not significant (p>0.05), ***p<0.001,***p<0.001 *p<0.05. Genotypes: N > tncRNAi (BG380-Gal4/+; UAS-tncRNAi/+); M > tncRNAi (UAS-tncRNAi/+; 24B-Gal4/+); tnc rescue control (UAS-tnc/+;tncEP/Df(3R)BSC655); N > tnc, tncEP/Df (UAS-tnc/+;tncEP/elav-Gal4,Df(3R)BSC655); M > tnc, tncEP/Df (UAS-tnc/+; tncEP/24B-Gal4, Df(3R)BSC655); N > mysRNAi (BG380-Gal4/+; UAS-Dcr-2/+; UAS-mysRNAi/+); M > mysRNAi (UAS-Dcr-2/+; UAS-mysRNAi/24B-Gal4); N > if RNAi (BG380-Gal4/+; UAS-if RNAi/UAS-Dcr-2); M > if RNAi (UAS-if RNAi/UAS-Dcr-2; 24B-Gal4/+).

Figure 3.

Figure 3—figure supplement 1. Additional control recordings.

Figure 3—figure supplement 1.

(A–B) Representative traces and summary bar graph for mEJPs frequency and amplitude recorded at 0.8 mM Ca2+ from muscle 6 of indicated genotypes. The number of samples examined is indicated in each bar. (C) Diagram of the fragments within the two UAS-tncRNAi lines utilized here relative to the known tnc transcripts. Bars indicate mean ± SEM. ns, not significant (p>0.05), ***p<0.001. Genotypes: N > tncRNAiRNAi-V (BG380-Gal4/+; UAS-tncRNAi-V/UAS-Dcr-2); M > tncRNAi (UAS-tncRNAi-V/UAS-Dcr-2; 24B-Gal4/+).